http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
AtriCure to Announce Third Quarter 2020 Financial Results
-
AtriCure to Participate at the Morgan Stanley 18th Annual Global Healthcare Conference
-
AtriCure (ATRC) Announces Angie Wirick as Chief Financial Officer
-
AtriCure Announces Angie Wirick as Chief Financial Officer
-
AtriCure to Participate at Upcoming Investor Conferences
-
AtriCure Reports Second Quarter 2020 Financial Results
-
AtriCure to Announce Second Quarter 2020 Financial Results
-
AtriCure Announces Results from CONVERGE IDE Clinical Trial
-
AtriCure Announces Investor Update Webcast on May 8, 2020 in Conjunction with the 41st Annual Heart Rhythm Society (HRS) Virtual Meeting
-
AtriCure Reports First Quarter 2020 Financial Results
-
AtriCure to Participate at Upcoming Investor Conferences
-
AtriCure to Announce First Quarter 2020 Financial Results
-
AtriCure (ATRC) Announces CONVERGE IDE Trial Results Accepted for Late-Breaking Clinical Trial Sessions at Annual HRS Meeting
-
AtriCure Announces CONVERGE IDE Trial Results Accepted for Late-Breaking Clinical Trial Sessions at Annual Heart Rhythm Society (HRS) Meeting
-
AtriCure (ATRC) Reports Prelim. 1Q Revenue Results Below Consensus; Withdraws FY20 Guidance
-
AtriCure Announces Preliminary Financial Results for First Quarter 2020 and Provides COVID-19 Pandemic Update
-
AtriCure Reports Fourth Quarter 2019 and Full Year 2019 Financial Results
-
AtriCure to Participate at the SVB Leerink 9th Annual Global Healthcare Conference
-
AtriCure to Announce Fourth Quarter and Full Year 2019 Financial Results
-
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2019, Provides Financial Outlook for 2020
-
AtriCure Announces Successful Completion of Patient Enrollment of aMAZE Clinical Trial and FDA Approval of Continued Access Protocol
-
AtriCure to Participate at the 38th Annual JP Morgan Healthcare Conference
-
AtriCure (ATRC) Appoints Karen Prange and Daniel Florin to Board
-
AtriCure Names Two Industry Veterans to Board of Directors
-
AtriCure to Participate at the Piper Jaffray 31st Annual Healthcare Conference
-
AtriCure Reports Third Quarter 2019 Financial Results
-
AtriCure to Participate in Upcoming Investor Conferences
-
AtriCure to Announce Third Quarter 2019 Financial Results
-
AtriCure Receives Clearance for Expanded Labeling Claims for AtriClip Devices
-
AtriCure to Participate at the Morgan Stanley 17th Annual Global Healthcare Conference
-
AtriCure Completes Acquisition of SentreHEART
-
AtriCure (ATRC) Reports Acquisition of SentreHEART; Provides Updated FY19 Revenue Outlook
-
AtriCure Enters Into Definitive Agreement to Acquire SentreHEART
-
AtriCure Reports Second Quarter 2019 Financial Results
-
AtriCure to Participate at the Canaccord Genuity 39th Annual Growth Conference
-
AtriCure to Announce Second Quarter 2019 Financial Results
-
AtriCure Reports First Quarter 2019 Financial Results
-
AtriCure Announces First Patient Enrollment in the DEEP IDE Trial Restart
-
AtriCure to Announce First Quarter 2019 Financial Results
-
AtriCure to Present at the Needham & Company’s 18th Annual Healthcare Conference
-
AtriCure Reports Fourth Quarter and Full Year 2018 Financial Results
-
AtriCure Announces The Society of Thoracic Surgeons Has Endorsed the Company’s Advanced Ablation Courses in the United States
-
AtriCure Announces Launch of the cryoICE® cryoSPHERE™ Probe
-
AtriCure (ATRC) Reports First Patient Enrollment in ICE-AFIB Clinical Trial
-
AtriCure Announces the First Patient Enrolled in the ICE-AFIB™ Clinical Trial
-
AtriCure to Announce Fourth Quarter and Full Year 2018 Financial Results
-
AtriCure (ATRC) Reports Prelim. 4Q & FY18 Revenue Results Above Consensus; Offers FY19 Revenue Mid-Point Outlook Above Guidance
-
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2018
-
AtriCure to Present at the 37th Annual J.P. Morgan Healthcare Conference
-
AtriCure to Present at the Piper Jaffray 30th Annual Healthcare Conference

